How Intrauterine insemination work?
Table of Contents
Key takeaways
- IUI places prepared sperm into the womb around ovulation, but suitability depends on fertility assessment.
- IUI may use partner sperm or donor sperm, and counselling may be important when donor sperm is involved.
- Success varies by age, diagnosis, ovulation, sperm quality and number of cycles; no outcome is certain.
- Risks, monitoring, multiple pregnancy risk and next steps after unsuccessful cycles should be clear before treatment.
Overview
Intrauterine insemination places prepared sperm into the womb around ovulation and needs fertility assessment first.
The original article and the current thin local draft were reviewed before rewriting. This replacement keeps the same reader intent but rebuilds it with current WHM structure, British English, assessment-first language, specific safety advice and authority sources.
Intrauterine insemination is a fertility treatment in which a prepared sperm sample is placed into the womb around ovulation. It may be done in a natural cycle or with ovulation-stimulating medicines. It is less invasive than IVF, but it is not suitable for every fertility situation.
Who it may suit
IUI may be discussed for some people using donor sperm, same-sex female couples, single women, sexual difficulties that make intercourse difficult, or selected cases of unexplained infertility or mild male factor issues. Suitability depends on ovulation, open fallopian tubes, sperm quality, age and clinical history.
If fallopian tubes are blocked, ovulation is absent and not corrected, sperm quality is very low, or age-related fertility decline is significant, IVF or another pathway may be more appropriate. Assessment should happen before treatment is chosen.
How IUI works
The cycle usually involves tracking ovulation with urine tests, ultrasound or blood tests. A sperm sample is prepared in a laboratory to concentrate motile sperm. A thin catheter then places the sample through the cervix into the womb. The procedure is usually brief, though mild cramps or spotting can happen.
Stimulated IUI uses medicines to encourage ovulation. Monitoring matters because too many follicles can increase multiple pregnancy risk, and a cycle may need to be cancelled if risk is too high.
Donor sperm or partner sperm
When donor sperm is used, the clinic should explain screening, consent, legal parenthood, donor information, limits on donor families and future implications for the child. Counselling gives space to discuss emotional, legal and practical questions before treatment.
Partner sperm IUI may be considered when semen parameters and other fertility factors make it reasonable. The couple should understand why IUI is being offered instead of expectant management, ovulation induction alone or IVF.
Success, risks and limitations
Success varies and is strongly influenced by age, diagnosis, sperm quality, ovulation and number of cycles. Clinics should provide personalised estimates where possible and avoid implying certainty. Repeated unsuccessful cycles should trigger review rather than automatic continuation.
Risks can include mild discomfort, spotting, infection, ovarian hyperstimulation if medicines are used, multiple pregnancy and emotional strain. The plan should explain when to test, what symptoms need urgent help and what the next step is if the cycle does not work.
When to seek medical advice
Seek urgent advice after IUI for severe pelvic pain, heavy bleeding, fever, fainting, shortness of breath, severe bloating or symptoms of ovarian hyperstimulation. Use NHS 111 for urgent advice or call 999 in a life-threatening emergency.
Reader checklist
A useful clinical review should define the main problem, how long it has been present, what makes it better or worse, which treatments have already been tried, and what outcome would matter most to the patient. This prevents the consultation from becoming a generic conversation and helps the clinician decide whether examination, testing, referral, self-care or urgent action is needed.
Readers should also write down red flags before an appointment, because worrying symptoms are easy to minimise when embarrassed or rushed. New bleeding, severe pain, fever, fainting, pregnancy concerns, unexplained weight loss, new lumps, safeguarding worries or symptoms after assault should be mentioned clearly and early so the clinician can prioritise safety.
The biological reason symptoms happen is often as important as the symptom name. Hormones, immune activity, infection, tissue support, nerve sensitivity, blood supply, inflammation and cell changes can all affect women’s health symptoms. Understanding the likely mechanism helps explain why one person needs reassurance and self-care, while another needs swabs, blood tests, imaging, biopsy, specialist referral or urgent treatment.
Follow-up should be part of the plan whenever symptoms are persistent, recurrent, severe or linked with a long-term condition. The reader should know what improvement would look like, how long treatment should take to work, which side effects are acceptable, which symptoms mean treatment is failing, and who to contact if the plan does not help. Without that review point, even sensible first-line advice can become unsafe.
It is also worth checking medicines, allergies, pregnancy possibility, breastfeeding, menopause status, immune suppression, diabetes, cancer history, previous pelvic surgery and past trauma where relevant. These details can change which tests are appropriate and which treatments are safe. A personalised plan is more useful than a generic list of remedies because the same symptom can have several different causes.
If the topic affects sex, fertility, continence, bleeding, cancer worry or intimate symptoms, emotional impact should be acknowledged. Anxiety, embarrassment, relationship strain and avoidance of sex or exercise can be part of the clinical picture. Compassionate care does not mean overpromising results; it means giving accurate information, clear options and a route back for review.
Readers should be cautious with online advice that offers a single cause or a quick fix for intimate or reproductive symptoms. A symptom such as pain, bleeding, discharge, dryness, fertility difficulty or fatigue may need a different approach depending on age, cycle timing, infection risk, menopause status, medical history and examination findings. The safest advice is specific about uncertainty and clear about when professional assessment is needed.
The article should also help a reader prepare for shared decision-making. Useful questions include what diagnosis is most likely, what else has been ruled out, what tests are needed, what treatment is being offered, what benefits are realistic, what side effects or risks matter, what alternatives exist, and when to come back. These questions turn passive reassurance into a safer, more practical care plan.
Where specialist referral is suggested, it does not mean the outcome is necessarily serious. Referral can be needed for confirmation, complex symptoms, failed first-line care, cancer exclusion, fertility planning, surgery discussion, persistent infection, or symptoms affecting quality of life. Explaining the reason for referral reduces fear and helps the reader understand why waiting silently is not the best option.
Before IUI, assessment should usually clarify ovulation, tubal patency, semen quality, infection screening, age, duration of infertility and whether donor sperm or partner sperm is being used. If the tubes are blocked or sperm parameters are unsuitable, another pathway may be more appropriate.
The cycle plan should explain monitoring, timing, whether medicines are used, how sperm is prepared, what discomfort is expected, when to test for pregnancy and what happens if the cycle is unsuccessful. People should also understand cancellation criteria, multiple pregnancy risk and how many cycles are reasonable.
Emotional and practical planning matters because IUI can involve repeated appointments, waiting, uncertainty and cost or funding decisions. Counselling is particularly important when donor sperm is used, including legal parenthood, donor information and future child considerations.
Sources
- NHS, Artificial insemination: https://www.nhs.uk/conditions/artificial-insemination/
Relevance: Explains intrauterine insemination, donor sperm, process, eligibility considerations and risks. - NICE CG156, Fertility problems: https://www.nice.org.uk/guidance/cg156/chapter/Recommendations
Relevance: Provides UK fertility guidance on assessment, intrauterine insemination and assisted reproduction pathways. - NHS, Infertility: https://www.nhs.uk/conditions/infertility/
Relevance: Supports wider infertility causes, diagnosis and treatment context. - HFEA, Intrauterine insemination: https://www.hfea.gov.uk/treatments/explore-all-treatments/intrauterine-insemination-iui/
Relevance: Provides UK fertility regulator information on IUI process, donor sperm, risks and treatment considerations.
Disclaimer
Educational only. Results vary. Not a cure.